Target intelligence / Profile preview

Protein phosphatase 3 catalytic subunit alpha (Calcineurin A) (PPP3CA)

Target
PPP3CA
Molecular classification
Enzyme, Serine/threonine protein phosphatase, Calmodulin-binding protein
01

Overview

Calcineurin is a calcium- and calmodulin-dependent serine/threonine protein phosphatase that serves as a critical junction in T-cell activation pathways (UniProt P16298). It consists of a catalytic subunit, Calcineurin A, and a regulatory subunit, Calcineurin B. The enzyme's primary biological role is the dephosphorylation of the Nuclear Factor of Activated T-cells (NFAT), a step required for NFAT's translocation into the nucleus to induce the expression of interleukin-2 (IL-2) and other pro-inflammatory cytokines (StatPearls, Calcineurin Inhibitors). In the context of pharmacology, Calcineurin A is the target of the immunosuppressant Cyclosporine A. Cyclosporine first binds to the intracellular immunophilin Cyclophilin A; this binary complex then binds to Calcineurin A, sterically blocking its active site and inhibiting its phosphatase activity (DrugBank DB00091). This inhibition effectively suppresses the immune response, making it a vital target for preventing organ transplant rejection and managing autoimmune diseases like psoriasis and rheumatoid arthritis (PubMed PMID: 1703530). However, therapeutic use is limited by significant safety concerns, most notably dose-dependent nephrotoxicity and neurotoxicity.

Other names
CalcineurinPPP3CACalcineurin AProtein phosphatase 2B catalytic subunit alphaCALNACNA1CCN1Calcineurin A-Cyclophilin A complex
02

Mechanism of action

Inhibition of Calcineurin phosphatase activity through the formation of a drug-immunophilin (Cyclosporine-Cyclophilin A) complex that sterically hinders the enzyme's active site, preventing the dephosphorylation of NFAT.

03

Biological functions

Signal transductionImmune responseCalcium signalingT-cell activationDephosphorylation of NFATProtein dephosphorylation
04

Disease associations

Organ transplant rejectionAutoimmune diseaseInflammationGraft-versus-host diseasePsoriasisRheumatoid arthritisNephrotic syndrome
05

Safety considerations

Nephrotoxicity (acute and chronic)Neurotoxicity (tremors, seizures)HypertensionHyperglycemia and New-Onset Diabetes After Transplantation (NODAT)Increased risk of opportunistic infectionsGingival hyperplasiaHirsutismElectrolyte imbalances (hyperkalemia, hypomagnesemia)
06

Interacting drugs

Cyclosporine

1 more in the full profile.

07

Biomarkers

Interleukin-2 (IL-2) expression levelsNFAT dephosphorylation statusCalcineurin phosphatase activity in peripheral blood mononuclear cells (PBMCs)Cyclosporine trough levels (C0)T-cell proliferation assays

Beyond the preview

Go deeper on Protein phosphatase 3 catalytic subunit alpha (Calcineurin A) (PPP3CA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase 3 catalytic subunit alpha (Calcineurin A) (PPP3CA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call